[ad_1] The Nasdaq Composite climbed for a third consecutive day as shares of Nvidia, Amazon.com and Google parent Alphabet advanced. The tech-heavy index added 0.1%, leaving it down 1% in…
Tag: ILMN
Illumina to Divest Itself of Cancer-Test Maker Grail
[ad_1] Updated Dec. 17, 2023 8:16 pm ET Gene-sequencing company Illumina said Sunday it will divest itself of cancer blood test maker Grail, following Illumina’s loss in its legal battle…
Court Sides With FTC Finding Illumina-Grail Deal Anticompetitive
[ad_1] A federal appeals court said the U.S. government was right to challenge Illumina’s purchase of cancer-test developer Grail, but still sent the case back to the Federal Trade Commission…
Blood-Test Customers Mistakenly Told They May Have Cancer
[ad_1] Grail said its telemedicine vendor sent the inaccurate forms to 400 people because of a software glitch. [ad_2] Source link
FTC Rejects Illumina’s $7 Billion Deal for Cancer-Test Developer Grail
[ad_1] The agency said the combination would hurt competition for cancer-detection tests while raising prices. [ad_2] Source link